The list of science and technology stocks with great performance has come to Beishang capital warehouse electronic leader

category:Finance
 The list of science and technology stocks with great performance has come to Beishang capital warehouse electronic leader


According to the data of the third quarter report and performance forecast, the statistics of securities times and data treasure show that more than 60% of the listed companies in the four major industries, such as electronics, communication, computer, medicine and biology, have a year-on-year increase in net profit in the first three quarters. The net profit of 162 shares increased by more than 20% on a year-on-year basis. Among them, the net profit of 8 technology stocks increased by more than 10 times over the same period of last year, including Shengxiang biology, Shennan shares, Santai holdings, Zhende medical, rapoo technology, Daan gene, Tongfu micro electronics, Kangtai medicine, etc.

Shengxiang biological Co., Ltd. ranks the first in terms of net profit growth. The company expects the net profit in the first three quarters to be 1.97 billion yuan to 2.07 billion yuan, with a year-on-year increase of 10472.64% to 11009.32%. Due to the uncertainty of the development of the global new crown epidemic, especially in the third quarter of 2020, the overseas epidemic will recur, and even the second wave of epidemic will appear in some countries. Moreover, the investment in preventing the co epidemic of Xinguan and influenza and avoiding cross infection will drive the companys demand for new crown nucleic acid detection reagents, nuclear acid detection instruments and related consumables by a large margin. Shengxiang biological instrument sales and installed capacity growth will further drive the companys incremental sales of reagents, with a total sales of nearly 3500 units in the first three quarters of this year.

Among the stocks with the highest performance growth, more from the pharmaceutical industry, including Zhende medical, Daan gene, Kangtai medicine, Huada gene and Mingde bio, are pharmaceutical stocks. In addition, electronic stocks such as Tongfu microelectronics, * ST Fenda, Jingfang technology, Derun electronics, Tianhua ultra clean, etc. also increased significantly.

Capital of Beishang increased its holding of electronic leading position

After the national day, the focus is still on science and technology. Data show that since October, Beishang capital has increased its holdings of more than one million shares, such as Lixun precision, meiyabaike, Shanghai Laishi, Yiling pharmaceutical, shunluo electronics, etc. Lixun precision, a leader in the electronics industry, won the lead in Beishang capitals increase of 7.4697 million shares, with a market value of 25.71 billion yuan. As early as in the semi annual report, Lixun precision had forecast the performance of the first three quarters. The company expected the net profit of the first three quarters to be 4.043 billion yuan to 4.62 billion yuan, with a year-on-year increase of 40% to 60%.

On the contrary, 28 shares were reduced by more than one million shares by Beishang capital. Among them, XinHeCheng, Watson biology, Dahua shares, Huatian technology, Shenzhen Science and technology were reduced by more than 10 million shares by Beishang capital, and XinHeCheng was the largest, reaching 29 million shares. On September 2, XinHeCheng reached an all-time high, with a cumulative correction of nearly 20%.

Zhengyuan wisdom: stock and convertible bonds suspension verification

However, just yesterday evening, Zhengyuan wisdom, A-share company which is the No.1 hot spot of convertible bonds, received a letter of concern from the Shenzhen Stock Exchange, asking the company to fully prompt the investors of operational risks and performance fluctuation risks in combination with the macro market environment, industry conditions and specific business conditions. In addition, Zhengyuan wisdom is required to analyze in detail the reasons why the price of its convertible bonds has increased greatly and deviated from the trend of the stock price. Subsequently, Zhengyuan wisdom announced that the trading of the companys shares and convertible corporate bonds (bond abbreviation: Zhengyuan convertible bonds, bond Code: 123043) will be suspended from the opening of the market on October 23, 2020. The company will conduct necessary verification on the related matters of the recent secondary market transactions, and resume trading after the company has completed the relevant verification work and disclosed the verification results. Source: Securities Times editor in charge: Yang Bin_ NF4368

However, just yesterday evening, Zhengyuan wisdom, A-share company which is the No.1 hot spot of convertible bonds, received a letter of concern from the Shenzhen Stock Exchange, asking the company to fully prompt the investors of operational risks and performance fluctuation risks in combination with the macro market environment, industry conditions and specific business conditions. In addition, Zhengyuan wisdom is required to analyze in detail the reasons why the price of its convertible bonds has increased greatly and deviated from the trend of the stock price. Subsequently, Zhengyuan wisdom announced that the trading of the companys shares and convertible corporate bonds (bond abbreviation: Zhengyuan convertible bonds, bond Code: 123043) will be suspended from the opening of the market on October 23, 2020. The company will conduct necessary verification on the related matters of the recent secondary market transactions, and resume trading after the company has completed the relevant verification work and disclosed the verification results. (data treasure Liang Qiangang)